Dr. Filio Billia is a member of the Division of Cardiology at the University health Network and a Scientist at the Toronto General Research Institute. She completed her medical and research training at the University of Toronto. Recently she completed a post-doctoral fellowship with the world-renowned Dr. Tak W. Mak at the Campbell Family Institute for Cancer Research. She currently is the co-Director of the Peter Munk Cardiovascular Biobank and Medical Director of the Mechanical Circulatory Assist Program. She has embarked in her own research career with funding from the Canadian Institutes of Health Research.
Industry Expertise (2)
Areas of Expertise (5)
Young Investigator Award
University of Toronto: M.D., Medicine 2011
University of Toronto: Ph.D., Cardiology 2007
Media Appearances (4)
Cancer Research Opens Doors to New Heart Therapies
Dr. Phyllis Billia and her team of researchers have shown that heart cell regeneration is possible – but that a heart cell’s ability to regenerate is suppressed by natural "roadblocks".
It’s believed that if these roadblocks can be removed, heart cells would be able to regenerate and multiply, potentially repairing damage caused by an injury – like a heart attack – to the heart.
“Something prevents heart muscle cells from regenerating,” said Dr. Billia. “So, when the heart’s cells are damaged, the effect is irreversible.”...
Heart transplant saves Krystina’s life, but fight for survival was just beginning
The Hamilton Spectator
Henniker asked her physician, Dr. Filio (Phyllis) Billia, to hold her hand on the way to the operating room. Billia told her she would be OK...
Krinos Taste of the Danforth 2014
GreekTown has also donated to Dr. Phyllis Billia's cancer research at Toronto General and Toronto Western Hospitals. GreekTown naturally supports a number of Greek initiatives, including donating to University of Toronto's Greek studies program, the Greek Community, the Hellenic Canadian Federation of Ontario, Nefeli (theatre and dance), Greek Orthodox Community of Mississauga, and Hellenic Home for the Aged...
Heart scientists discover protein that may be 1 cause of heart failure
"Our research suggests that PINK1 is an important switch that sets off a cascade of events affecting heart cell metabolism," says Dr. Phyllis Billia, principal author, clinician‑scientist and heart failure specialist at the Peter Munk Cardiac Centre. "This could be one of the inciting events in the development of heart failure."...
Patients in intensive care units are disconnected from their natural environment. Synchrony between environmental diurnal rhythms and intracellular circadian rhythms is essential for normal organ biology; disruption causes pathology. Whether ...
Aortic valve disease in the setting of a left ventricular assist device presents unique challenges. We present the case of a patient who underwent transcatheter aortic valve implantation to replace a stenotic aortic valve to facilitate left ventricular assist device explantation...
Cardiac consequences of obesity include inflammation, hypertrophy, and compromised energy metabolism. Glucagon-like peptide-1 is an incretin hormone capable of cytoprotective actions that reduces inflammation and endoplasmic reticulum stress in ...
Oxidative stress is caused by an imbalance between the production of reactive oxygen species (ROS) and the ability of an organism to eliminate these toxic intermediates. Although the Parkinson-susceptibility gene, Parkinson protein 7/DJ-1 (DJ-1), has been ...
The HeartWare ventricular assist device (HVAD) is a new generation centrifugal flow VAD recently introduced in Canada. The objective of this study was to compare the HVAD device to the HeartMate II (HMII) axial flow device. Very few studies have compared ...